US Stock MarketDetailed Quotes
OTLKW Outlook Therapeutics Inc C/Wts 18/02/2022(To Pur Com) Ser A
- 0.000
- 0.0000.00%
Close Dec 20 09:30 ET
0Market Cap0.00P/E (TTM)
0.000High0.000Low0Volume0.000Open0.000Pre Close0.00Turnover0.00%Turnover Ratio0.00P/E (Static)0Shares0.05052wk High0.00P/B0Float Cap0.01052wk Low--Dividend TTM0Shs Float3.490Historical High--Div YieldTTM0.00%Amplitude0.010Historical Low--Avg Price1Lot Size
Outlook Therapeutics Inc C/Wts 18/02/2022(To Pur Com) Ser A Key Stats
Quarterly+Annual
YOY
| (Q1)Dec 31, 2021 | (FY)Sep 30, 2021 | (Q4)Sep 30, 2021 | (Q3)Jun 30, 2021 | (Q2)Mar 31, 2021 | (Q1)Dec 31, 2020 | (FY)Sep 30, 2020 | (Q4)Sep 30, 2020 | (Q3)Jun 30, 2020 | (Q2)Mar 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 17.52%-10.99M | -70.66%-54.25M | 25.56%-8.99M | -239.05%-20.19M | -65.83%-11.75M | -99.66%-13.32M | 1.55%-31.79M | -103.25%-12.08M | 42.22%-5.96M | -13.16%-7.08M |
| Net income from continuing operations | -0.05%-14.46M | -50.86%-53.16M | -35.10%-13.4M | -304.55%-12.2M | -129.94%-13.11M | 12.93%-14.46M | -2.07%-35.24M | 1.73%-9.92M | 32.11%-3.01M | 44.36%-5.7M |
| Operating gains losses | 658.82%799.16K | -70.87%498.49K | -172.23%-300.34K | 107.70%464.68K | 30,051.31%228.83K | -98.66%105.32K | 193.47%1.71M | 35.99%-110.33K | -300.43%-6.04M | -100.05%-764 |
| Depreciation and amortization | -37.29%50.87K | -52.69%262.14K | -36.78%50.67K | -60.60%48.18K | -53.39%82.17K | -53.74%81.12K | -83.52%554.07K | -90.98%80.15K | -85.33%122.3K | -78.41%176.28K |
| Other non cash items | 186.94%507.07K | 138.75%341.55K | --253.67K | -68.18%248.19K | 125.80%422.9K | -2,524.38%-583.22K | -167.06%-881.33K | --0 | 86.10%779.87K | -468.41%-1.64M |
| Change In working capital | 144.06%911.33K | -457.56%-7.08M | 203.26%3.01M | -1,461.91%-9.96M | 22.26%-503.28K | -76.02%373.41K | 90.38%-1.27M | 42.65%-2.91M | 112.98%730.97K | -258.21%-647.4K |
| -Change in prepaid assets | -1,107.46%-285.5K | -457.56%-1.73M | 624.35%5.17M | -1,348.76%-5.58M | -2,178.46%-1.35M | -90.19%28.34K | 90.44%-310.27K | -112.15%-986.83K | 116.50%446.95K | -183.16%-59.31K |
| -Change in payables and accrued expense | 377.44%1.21M | -617.49%-5.5M | -14.74%-2.16M | -1,500.76%-4.49M | 248.95%894.55K | -81.88%252.83K | 57.69%-766.23K | -254.80%-1.88M | 112.91%320.28K | -152.92%-600.57K |
| -Change in other current assets | --0 | 454.88%298.52K | --0 | 21,221.26%160.94K | --0 | 218.95%137.58K | 3.51%-84.12K | --0 | 99.50%-762 | 56.73%32.31K |
| -Change in other current liabilities | 77.36%-10.27K | -37.81%-150.35K | 76.29%-10.07K | -36.81%-48.55K | -133.89%-46.39K | -301.73%-45.34K | ---109.1K | ---42.49K | ---35.49K | ---19.83K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 17.52%-10.99M | -70.66%-54.25M | 25.56%-8.99M | -239.05%-20.19M | -65.83%-11.75M | -99.66%-13.32M | 1.55%-31.79M | -103.25%-12.08M | 42.22%-5.96M | -13.16%-7.08M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 0 | 0 | -105.81%-900K | 0 | ||||||
| Net business purchase and sale | ---- | --0 | --0 | ---- | ---- | ---- | ---900K | --0 | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | ---- | --0 | --0 | ---- | ---- | ---- | -105.81%-900K | --0 | ---- | ---- |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 948.65%66.66M | 51.02%56.19M | 471.37%3.78M | -89.62%2.72M | 316.70%43.35M | 76,756.38%6.36M | -4.65%37.21M | 1,059.78%660.77K | 7.51%26.16M | 66.78%10.4M |
| Net issuance payments of debt | 50.69%9.59M | 884.12%6.31M | 35.73%-19.72K | -102.20%-19.23K | 86.17%-18.76K | 9,661.44%6.37M | 109.23%640.92K | 55.43%-30.69K | 147.70%873.78K | 91.95%-135.6K |
| Net common stock issuance | --57.65M | 30.68%46.3M | 447.77%3.79M | -89.18%2.73M | --39.78M | --0 | -22.92%35.43M | 69,145,500.00%691.46K | -3.34%25.28M | ---- |
| Proceeds from stock option exercised by employees | --17.75K | 215.51%3.59M | --7.57K | --0 | 231.83%3.59M | --0 | 26,081.61%1.14M | --0 | --0 | --1.08M |
| Net other financing activities | -7,370.12%-600K | ---8.03K | --0 | --0 | --0 | ---8.03K | ---- | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 948.65%66.66M | 51.02%56.19M | 471.37%3.78M | -89.62%2.72M | 316.70%43.35M | 76,756.38%6.36M | -4.65%37.21M | 1,059.78%660.77K | 7.51%26.16M | 66.78%10.4M |
| Net cash flow | ||||||||||
| Beginning cash position | 15.49%14.48M | 56.40%12.54M | -17.79%19.69M | 698.83%37.17M | 317.56%5.57M | 56.40%12.54M | 366.73%8.02M | 70.77%23.95M | 2,892.85%4.65M | 485.62%1.33M |
| Current changes in cash | 899.04%55.67M | -57.05%1.94M | 54.33%-5.21M | -190.55%-17.48M | 852.00%31.6M | -4.27%-6.97M | -28.23%4.52M | -89.93%-11.42M | 39.14%19.3M | 4,694.40%3.32M |
| End cash Position | 1,159.79%70.15M | 15.49%14.48M | 15.49%14.48M | -17.79%19.69M | 698.83%37.17M | 317.56%5.57M | 56.40%12.54M | 56.40%12.54M | 70.77%23.95M | 2,892.85%4.65M |
| Free cash flow | 17.52%-10.99M | -70.66%-54.25M | 25.56%-8.99M | -239.05%-20.19M | -65.83%-11.75M | -99.66%-13.32M | 2.86%-31.79M | -103.25%-12.08M | 43.05%-5.96M | -12.26%-7.08M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- |
Heat List
US
Overall
Symbol
Price
% Chg
No Data